Pulmonary rehabilitation is a comprehensive intervention based on a thorough patient assessment followed by patient tailored therapies that include, but are not limited to, exercise training, education, and behavior change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors”
Pulmonary rehabilitation is a comprehensive intervention based on a thorough patient assessment followed by patient tailored therapies that include, but are not limited to, exercise training, education, and behavior change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors”
This is a journal article critique on a research which is entitled " INSPIRATORY MUSCLE TRAINING TO ENHANCE RECOVERY FROM MECHANICAL VENTILATION; A RANDOMIZED TRIAL"
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
CYSTIC FIBROSIS AND PHYSIOTHERAPY TREATMENT.pptxShilpasree Saha
Physiotherapy has long been considered a cornerstone of condition management for
people with cystic fibrosis (CF). The presentation of CF has changed over time with an increased
life expectancy and increased expectations of people with CF to have a complete lifestyle.
Etiopathogenesis and pharmacotherapy of CONGESTIVE CARDIAC FAILURE
a. the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response and adverse effects).
This is a journal article critique on a research which is entitled " INSPIRATORY MUSCLE TRAINING TO ENHANCE RECOVERY FROM MECHANICAL VENTILATION; A RANDOMIZED TRIAL"
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
CYSTIC FIBROSIS AND PHYSIOTHERAPY TREATMENT.pptxShilpasree Saha
Physiotherapy has long been considered a cornerstone of condition management for
people with cystic fibrosis (CF). The presentation of CF has changed over time with an increased
life expectancy and increased expectations of people with CF to have a complete lifestyle.
Etiopathogenesis and pharmacotherapy of CONGESTIVE CARDIAC FAILURE
a. the pathophysiology of selected disease states and the rationale for drug therapy;
b. the therapeutic approach to management of these diseases;
c. the controversies in drug therapy;
d. the importance of preparation of individualised therapeutic plans based on diagnosis;
e. needs to identify the patient-specific parameters relevant in initiating drug therapy,
and monitoring therapy (including alternatives, time-course of clinical and laboratory
indices of therapeutic response and adverse effects);
f. describe the pathophysiology of selected disease states and explain the rationale for
drug therapy;
g. summarise the therapeutic approach to management of these diseases including
reference to the latest available evidence;
h. discuss the controversies in drug therapy;
i. discuss the preparation of individualised therapeutic plans based on diagnosis; and
j. identify the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response and adverse effects).
Heart failure is a clinical syndrome that results when the heart is unable to provide sufficient blood flow to meet metabolic requirements or accommodate systemic venous return.
Definition
Causes
Pathophysiology
Types Of Heart Failure
Symptoms
Signs
Complications
Investigations
Treatment
Heart failure is a clinical syndrome that develops when –
The heart can not maintain adequate output
or
Can do so only at the expense of elevated ventricular filling pressure
heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular failure causes shortness of breath and fatigue, and right ventricular failure causes peripheral and abdominal fluid accumulation; the ventricles can be involved together or separately. Diagnosis is initially clinical, supported by chest x-ray, echocardiography, and levels of plasma natriuretic peptides. Treatment includes patient education, diuretics, ACE inhibitors, angiotensin II receptor blockers, beta-blockers, aldosterone antagonists, neprilysin inhibitors, specialized implantable pacemakers/defibrillators and other devices, and correction of the cause(s) of the HF syndrome.
Journal club covid vaccine neurological complications ZIKRULLAH MALLICK
the risks of adverse neurological events following SARS-CoV-2 infection are much greater than those associated with vaccinations, highlighting the benefits of ongoing vaccination programs.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Age related changes in cvs and respiratory system
1. Age related anatomical and
physiological changes in
cardiovascular and respiratory
system and anaesthetic implications.
DR.ZIKRULLAH
2. • The importance of pulmonary and cardiovascular physiology
to anesthetic practice is obvious.
• Anaesthetic success and failures are often directly related to
the skill of the practitioner in manipulating cardiovascular
and respiratory physiology.
• These systems undergoes progressive involution with age,
resulting in anatomical and functional changes that are
exerted on all levels.
3. • Changes in the cardiovascular anatomy and physiology that
occur with aging are responsible for the alterations in
function that are characteristic of aging.
• Respiratory system undergoes various structural,
physiological, and immunological changes with age.
4. Cardiovascular system:
• Major structural changes with aging ?
• Involves changes in :-
myocardium,
cardiac conduction system,
and, the endocardium.
5. Progressive degeneration of the cardiac structures with aging ?
• loss of elasticity,
• fibrotic changes in the valves of the heart,
• Infiltration with collagen and fat,
• Amyloid deposition,
• basophilic degeneration of cells.
6. • Age-associated structural characteristics that have the greatest
impact involve the contractility of the heart's left ventricular
wall.
• The pumping capacity of the heart is reduced with age due to
a variety of changes affecting the structure and function of
the heart muscle.
• An increase in heart mass with aging, is due to an increase in
the average myocyte size, whereas the number of myocardial
cells declines.
7. Physiological considerations in infants ?
• Stroke volume:- fixed by noncompliant and immature LV.
• CO:- sensitive to HR changes or HR dependent.
• Sympathetic nervous system ,baroreceptor reflexes are not
fully mature.
• Vagal parasympathetic tone dominant:-which makes
neonates and infants more prone to bradycardias.
8. Anaesthetic Implications:
• Immature heart -- more sensitive to depression by volatile
anesthetics and opioid-induced bradycardia.
• Intravascular volume depletion in neonates and infants may
be signaled by hypotension without tachycardia.
• Activation of parasympathetic nervous system, anaesthetic
overdose, or hypoxia -- trigger bradycardia -- profound
reductions in CO.
9. • Bradycardia associated with hypoxia : treat with oxygen and
ventilation initially.
• Patent ductus contracts in 1st few days of life & fibrose within
2-4 weeks.
• Closure of foramen ovale is pressure dependent & closes in
the first day of life.
• Neonatal pulmonary vasculature reacts to rise in PaO2 and
pH and fall in PaCO2 at birth.
10. Major age-related changes in the cardiovascular
system ?
• arterial stiffening;
• endothelial dysfunction, which promotes vasoconstriction;
• elevated systolic blood pressure and increased pulse pressure;
• increased left ventricular wall thickness;
• reduced early diastolic filling of the ventricles;
• impaired cardiac reserve;
• alterations in heart rate rhythm;
• prolonged cardiac action potential;
11. Age-related Changes In Vascular Function ?
Increased Wall Thickening and Arterial Stiffening
• Factors include increased collagen, reduced elastin, and
calcification
• decreased elasticity of the arterial vessels results in:-
• chronic or residual increases in vessel diameter
• vessel wall rigidity which impair the function of the vessel.
12. Endothelial Dysfunction
• reduction in endothelial
function.
• Reduction in amount of nitric
oxide (NO)produced by
endothelial cells.
Promotes vasoconstriction.
13. Blood vessels:
• Arteries lose elasticity , heart have to pump harder to
circulate blood.
• smaller arteries may thicken/stiffen :-
ability to dilate & constrict diminishes significantly.
• In veins age-related changes are minimal and do not impede
normal functioning.
15. Age related anatomical changes in heart valves?
• Increase in valvular circumference reported in all four cardiac
valves,greatest changes occurring in the aortic valve .
• The age-associated increase in valvular circumference does not appear
to be associated with valvular incompetence.
• Other valvular changes with aging include thickening and
calcification of the cusps and leaflets.
• Clinical heart murmurs are detected more frequently.
16. Age-Related Physiological Changes In Cardiac Function ?
• Heart Rate and Cardiac Output.
• Left Ventricular Wall Function.
• Myocardial Contraction.
17. Heart Rate and Cardiac Output:
• Resting heart rate does not change dramatically with age.
• In the supine position at rest, heart rate in older men does not
differ from that in younger men.
• Cardiac output at rest is unaffected by age. Maximum cardiac
output and aerobic capacity are reduced with age.
• lower cardiac output reserve in older subjects and contributes
to declining aerobic capacity in advancing age.
18. Left Ventricular Wall Function:
• Increased Wall Thickening and Arterial Stiffening ; systolic
blood pressure increases with age.
• Amount of blood, chambers can hold may decrease.
• Left ventricular filling during the early phase of diastole
slows after the age of 20 years.
• By the 80 years of age, the rate is approximately 50% of its
peak value observed in early life.
19. Myocardial Contraction:
• There is a decrease in myocyte number in the aging
myocardium.
• Excitation–contraction coupling in the cardiac myocyte
changes during aging.
• Prolonged myocardial contraction.
• This makes the heart less able to pump efficiently.
20. Changes in the autonomic system with aging ?
• Decrease in response to β-receptor stimulation.
• Decrease in sympathetic nervous system activity.
Catecholamine β adrenergic receptors in the myocardium are
down regulated in the elderly resulting in a decreased
responsiveness to catecholamine's and sympathomimetic
agents.
21. Age-Related Electrical Conduction System Changes in
the Heart ?
• Decrease in number of pacemaker cells in the Sino atrial
node with age.
• There is an increase in elastic and collagenous (fibrous)tissue
in all parts of the conduction system.
• Fat accumulates around the Sino atrial node.
• Physiological changes
• Irritability of the myocardium may result in extra systoles,
along with sinus arrhythmias & sinus bradycardia.
22. Features Of The Electrocardiogram Altered By
Normal Aging ?
Based on the structural changes with age .
• The P-R and Q-T intervals show small increases with age.
• There is a leftward shift of the QRS axis with advancing age.
• The S-T segment becomes flattened, and the amplitude of the
T wave diminishes.
23. Major Effects On Blood Pressure ?
• The aorta becomes thicker, stiffer, and less flexible.
• This makes the BP higher resulting in LV hypertrophy.
• Increased large artery stiffness causes a fall in DBP,
associated with a continual rise in SBP.
• Systolic BP rises disproportionately higher than diastolic.
• Higher SBP, left untreated, may accelerate large artery
stiffness and thus perpetuate a vicious cycle
24.
25. Anaesthetic implications :
• General anaesthesia :
• Almost all anaesthetic drugs have important actions on the
cardiovascular system.
• volatile anaesthetic agents:-
• Dose dependent myocardial depression & decrease in SBP
Halothane & enflurane :-attenuation of myocardial
contractile function.
Isoflurane & sevoflurane:- due to decrease in SVR.
• Lowers arrhythmogenic threshold to
epinephrine,(halothane>enflurane>sevoflrane>isoflurane).
26. i.v. induction agents:-
• Thiopentone
• Fall in BP & increase in HR.
• Tachycardia is due to central vagolytic effect (10-30%).
• CO & ABP is decreased due to :-
• Negative inotropic action & peripheral pooling of blood.
• Hence, caution should be used when thiopental is given to patients
with LVF/RVF, old age, or hypovolemia.
27. • Propofol
• Major CVS effect - decrease in ABP due to drop in SVR , cardiac
contractility & preload.
• Factors exacerbating hypotension include large doses, rapid injection,
& old age.
• Intravenous and inhalational agents depress cardiac and vascular
smooth muscle contractility and may impair the baroreceptor response
to hypotension.
28. Regional anaesthesia (spinal or epidural) ?
• Neuroaxial regional anaesthesia techniques are usefully employed in
this patient group however these techniques may result in significant
hypotension.
• Results in vasodilatation (reduced SVR) proportional to the height of
the block.
• Elderly patients often tolerate spinal anaesthesia well, as the non-
elastic vascular tree is not as susceptible to vasodilatation caused by
sympathetic blockade compared to younger patients.
29. Respiratory system:
• functionally, separated in two
zones;
conducting zones (nose to
bronchioles) form a path for
conduction of the inhaled
gases.
respiratory zone (alveolar duct
to alveoli) where the gas
exchange takes place.
30. • TRACHEOBRONCHIAL TREE
• Partitioned into 23
generations of dichotomous
branching, extending from
trachea to the last order of
bronchioles & alveolar sacs.
• From the trachea to the
terminal bronchioles the
airways are purely
conducting pipes.
31. • BRONCHO-PULMONARY
SEGMENT
• Defined as an area of
distribution of any bronchus.
• Each lobar bronchi divides
into segmental bronchi
(tertiary bronchi), which
supply the Broncho -
pulmonary segment of each
lobe.
32. Normal respiratory physiology ?
• Pressure gradients are
established by changes in
thoracic cavity.
• increase size in thorax = a
decrease in pressure --- air
moves in.
• Decrease size in thorax =
increase in pressure --- air
moves out.
33. • Tidal volume - It is the volume of air inspired or expired with each
breath during normal quiet breathing. (500 ml)
• Expiratory Reserve volume - additional amount of air forcibly expired
after normal tidal expiration (1000 - 1200 ml).
• Inspiratory Reserve volume –It is maximal volume of air which can be
inspired after a normal (tidal) inspiration.(1900-3300 ml).
• Residual volume - amount of air remaining in the lungs even after
forced expiration (about 1.2 liters).
34. Anatomical considerations in infants ?
• Large occiput.
• Large sized tongue.
• Larynx : more cephalic, funnel
shaped & anterior.
• Epiglottis : short, stubby, omega
shaped, angled over laryngeal inlet.
• Vocal cords angled.
• Cricoid cartilage : Narrowest
portion.
35. Anaesthetic implications ?
• No doughnut is required
• Straight blades preferred
• Uncuffed tubes preferred for children
‹6 yrs.
• Tube that easily passes the vocal cords
may be tight in the subglottic region.
• Micro cuff tube:-
• Safe ,very soft material.
36. Physiological consideration in infants ?
• Increased respiratory rate
• Reduced lung compliance
• Increased chest wall compliance
• Increased metabolic rate
• Reduced functional residual capacity
• Alveoli thick walled at birth
• Dead space ventilation similar to adults
• Oxygen consumption 2-3 times higher
• Work of breathing 3 times that in adults
37. • Weaker intercostal muscles , diaphragm.
• Horizontal , pliable ribs,
• Protuberant abdomen,
• Early fatigue and Desaturation.
39. • Decrease in FRC :limits oxygen reserves during periods of apnoea ,
predisposes to atelectasis and hypoxemia.
• Minute ventilation is rate dependent as there is little means to increase
tidal volume.
• Closing volume larger than FRC until 6-8 years.
• Causes an increased tendency for airway closure at end expiration.
40. Age related respiratory physiological changes ?
• Altered lung volumes.
• Altered resistance of peripheral airways.
• Decrease in elastic recoil of lungs.
• Changes in ventilation perfusion matching.
• Decreased compliance of chest walls and lungs.
• Ventilatory responses to hypercapnia , hypoxia and exercise decrease
in the elderly.
• The elasticity of the lung decreases with age.
41. Lung volume changes with age ?
• Residual Volume (RV) increases and Functional Residual Capacity
(FRC) remains unchanged.
• Total lung capacity (TLC),
• Forced Vital Capacity (FVC), all reduced as people age.
• Forced Expiratory Volume(FEV1),
• Vital Capacity.
• The annual decline in FEV1 is small at first but accelerates with age .
42. • The FEV1 decreases with age by about
27 mL/year in men but by only 22
mL/year in women .
• Forced vital capacity (FVC) decreases
as well, by about 14 to 30 mL/year in
men and 15 to 24 mL/year in women.
• The decreases in FEV1 and FVC that
occur until age 40 are thought to result
from changes in body weight and
strength rather than from loss of tissue.
43. Changes in Pulmonary Compliance ?
Lung and chest wall compliance decrease with advancing age.
Dead space increases with age because the larger airways increase in
diameter.
Elastic elements of the lung parenchyma are lost with age
Ageing is associated with a reduction in the number of small airways
and flattening of the internal surface of the alveoli.
The reduced diffusion capacity due to aging is induced from a decrease
in the lung area owing to damage to the alveoli, an increase in thickness
of the alveolar walls, and small-airways obstruction.
45. Age-related changes in the lung ?
• degeneration of elastin :- dilatation of alveolar ducts,
• reduction in number of small airways
• increased collagen cross-linking:- stiffer parenchyma,
• less distensible vessel walls.
• reduction in mucociliary function
• Calcification of ribs and sternum results in stiffening.
• Changes in respiratory muscles.
• Distal bronchioles have reduced diameter and tend to collapse.
46. • Lung tissues become less elastic and expansible.
• Decrease in compliance of the chest watt, due to calcification
of its articulations, dorsal kyphosis and "barrel chest".
• Decrease in the strength of respiratory muscles
• The increased static lung compliance combined with the
decreased chest watt compliance leads to an increase in the
functional residual capacity with aging.
47. Anaesthetic implications in elderly
more sensitive to anesthetic agents and generally require smaller doses
for the same clinical effect, and drug action is usually prolonged.
Airway obstruction:-
Patients are often edentulous making bag-mask ventilation difficult.
loss of airway patency due to the relaxation of the pharyngeal muscles
and posterior displacement of the tongue.
48. The supine position reduces the FRC by 0.8–1.0 L, and induction of
general anaesthesia further reduces the FRC by 0.4–0.5 L.(approx 15-
20%)
Spontaneous ventilation is frequently reduced during anesthesia.
Minimum alveolar anesthetic concentration (MAC), decreases
approximately 6% for every decade.
increasing V/Q mismatch with age.
49. Effect of anaesthetic agents ?
• All inhalational anesthetic agents depress respiratory function.
• Halothane causes rapid &shallow breathing.
• All (except ketamine, ether and nitrous oxide) cause a dose- dependent
reduction in ventilatory minute volume.
• This can be due :-
• ↓ in the respiratory rate (e.g. opioids)
• ↓in the tidal volume (e.g. volatile anaesthetics) or both (e.g. propofol).
50. Factors that influence respiratory function during
anesthesia?
• Spontaneous breathing,
• Increased Oxygen fraction,
• Body position (supine or lateral),
• Age,
• Obesity,
• Pre-existing lung diseases,
• Atelectasis & airway collapse,
• V/Q mismatch.
51. Preoperative evaluation:
• Common diseases in the elderly have a significant impact on
anesthesia and require special care.
• The risk from anesthesia is more related with the presence of co-
existing disease than with the age of the patient.
• Thus, it is more important to determine the patient’s status and
estimate the physiologic reserve in the preanesthetic evaluation.
52. Intraoperative care and anesthetic management:
• Advanced age and general anesthesia are associated with hypothermia.
• Maintenance of normothermia is important as hypothermia is related
to myocardial ischemia, and hypoxemia in the early postoperative
period.
53. • In case of general anesthesia it is of major importance to titrate drug
doses and it would be prudent to use short acting drugs.
• The duration of drug action may be prolonged if their metabolism
depends on renal or hepatic excretion.
• The elderly require less doses of opioids for pain relief.